News

1 to 9 of 20 results

Roche ups bid for Illumina; M&A speculation on Amylin, Actavis

29-03-2012

There was a plethora of merger and acquisition news coming out yesterday and this morning, first of which…

ActavisAmylinBiotechnologyBristol-Myers SquibbGenericsIlluminaMergers & AcquisitionsMylan LaboratoriesPharmaceuticalRocheWatson Pharmaceuticals

Fabiana Lacerca joins Mylan as its senior VP and chief compliance officer

24-09-2007

Fabiana Lacerca has joined US drugmaker Mylan Laboratories as senior vice president and chief compliance…

Bristol-Myers SquibbMylan Laboratories

B-MS and Somerset in Emsam distribution deal

10-01-2005

US drug major Bristol-Myers Squibb and Somerset Pharmaceuticals, a joint venture between Mylan Laboratories…

Bristol-Myers SquibbEmsamMylan LaboratoriesSelegiline Transdermal SystemTestosteronetransdermalWatson Pharmaceuticals

Teva stays ahead of the pack with $3.4 billion Sicor acquisition

10-11-2003

Israel's Teva Pharmaceutical has moved to consolidate its position asthe world's leading generics manufacturer…

AstraZenecaBristol-Myers SquibbCopaxoneFluoxetine HclGlatiramer AcetateLillyMerck KGaAMylan LaboratoriesNovartisNystatinOmeprazoleOralPrilosecProzacWatson Pharmaceuticals

Mylan reaches buspirone settlement with B-MS

03-03-2003

US generic drugmaker Mylan Laboratories has reached a final agreementwith Bristol-Myers Squibb which,…

Bristol-Myers SquibbBusparBuspironeMylan Laboratories

Abbott, NaPro get OK for generic Taxol in USA

13-05-2002

Abbott Laboratories and NaPro BioTherapeutics are set to become thelatest suppliers of a generic form…

Abbott LaboratoriesAmino AcidsBristol-Myers SquibbInjectionIvaxMylan LaboratoriesPaclitaxelPhysostigmine SalicylateTaxol

Mylan becomes second firm to offer generic paclitaxel in the USA

24-07-2001

Mylan Laboratories has been granted marketing approval from the US Foodand Drug Administration for its…

Abbott LaboratoriesAmino AcidsBristol-Myers SquibbInjectionIvaxMylan LaboratoriesPaclitaxelPhysostigmine SalicylateTaxol

B-MS' BuSpar open to generic competition after lawsuit verdict?

15-03-2001

Bristol-Myers Squibb has lost a lawsuit trying to block genericcompetition to its anxiolytic drug BuSpar…

Bristol-Myers SquibbBusparBuspironeMylan LaboratoriesWatson Pharmaceuticals

1 to 9 of 20 results

Back to top